Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
78 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01038804 | A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer | completed | Phase 2 | 101 | Astellas Pharma IncINDUSTRY | 8 | Sep 18, 2013 | clinicaltrials |
| NCT00750620 | A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment | completed | Phase 1 | 33 | Astellas Pharma IncINDUSTRY | 1 | Sep 5, 2013 | clinicaltrials |
| NCT01228760 | A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer | completed | Phase 1 | 46 | Astellas Pharma IncINDUSTRY | 1 | Jun 7, 2013 | clinicaltrials |
| NCT00698243 | Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 128 | Astellas Pharma IncINDUSTRY | 3 | Apr 15, 2013 | clinicaltrials |
| NCT00816686 | A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer | terminated | Phase 1 | 7 | Astellas Pharma IncINDUSTRY | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00816764 | A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer | completed | Phase 1 | 18 | Astellas Pharma IncINDUSTRY | 1 | Feb 27, 2013 | clinicaltrials |
| NCT01016054 | A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer | terminated | Phase 1 | 4 | Astellas Pharma IncINDUSTRY | 1 | Feb 27, 2013 | clinicaltrials |
| NCT01114230 | A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer | completed | Phase 1 | 26 | Astellas Pharma IncINDUSTRY | 1 | Dec 12, 2012 | clinicaltrials |
| NCT00048659 | YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy | terminated | Phase 2 | — | Astellas Pharma IncINDUSTRY | 10 | Jun 7, 2012 | clinicaltrials |
| NCT00050297 | YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer | terminated | Phase 2 | — | Astellas Pharma IncINDUSTRY | 7 | Jun 7, 2012 | clinicaltrials |
| NCT00257478 | A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy | completed | Phase 2 | — | Astellas Pharma IncINDUSTRY | 3 | Jun 7, 2012 | clinicaltrials |
| NCT00281541 | A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma | completed | Phase 2 | 29 | Astellas Pharma IncINDUSTRY | 1 | Jun 7, 2012 | clinicaltrials |
| NCT00046787 | Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer | completed | Phase 2 | 47 | Astellas Pharma IncINDUSTRY | 2 | Oct 20, 2011 | clinicaltrials |
| NCT00046800 | Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer | completed | Phase 2 | 80 | Astellas Pharma IncINDUSTRY | 2 | Oct 20, 2011 | clinicaltrials |
| NCT00072618 | Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients | completed | Phase 1 / Phase 2 | 52 | Astellas Pharma IncINDUSTRY | 1 | Oct 20, 2011 | clinicaltrials |
| NCT00085826 | A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients | completed | Phase 3 | 600 | Astellas Pharma IncINDUSTRY | 1 | Oct 20, 2011 | clinicaltrials |
| NCT00036036 | Study of CP-461 in Patients With Advanced Renal Cell Cancer | completed | Phase 2 | 14 | Astellas Pharma IncINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00036075 | Study Using CP-461 to Treat Advanced Prostate Cancer | completed | Phase 2 | 25 | Astellas Pharma IncINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00036257 | Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia | completed | Phase 1 | 15 | Astellas Pharma IncINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00060710 | CP-461 in the Treatment of Patients With Advanced Melanoma | terminated | Phase 2 | 35 | Astellas Pharma IncINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00073489 | A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL) | completed | Phase 2 | 23 | Astellas Pharma IncINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00513851 | Phase 1 Study of OSI-930 in Cancer Patients | completed | Phase 1 | 60 | Astellas Pharma IncINDUSTRY | 2 | Sep 27, 2011 | clinicaltrials |
| NCT00603356 | Phase I Study of OSI-930 and Erlotinib in Cancer Tumors | completed | Phase 1 | 60 | Astellas Pharma IncINDUSTRY | 2 | Sep 27, 2011 | clinicaltrials |
| NCT00106392 | A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy | completed | Phase 4 | 131 | Astellas Pharma IncINDUSTRY | 1 | Nov 23, 2010 | clinicaltrials |
| NCT01023386 | A Clinical Pharmacological Study of YM155 After Intravenous Infusion in Patients With Advanced Cancer | completed | Phase 1 | 6 | Astellas Pharma IncINDUSTRY | 1 | Apr 13, 2010 | clinicaltrials |
| NCT00811876 | Retrospective, Non-interventional Study of Depo-Eligard®.(OCT) | completed | — | 140 | Astellas Pharma IncINDUSTRY | 1 | Jan 22, 2010 | clinicaltrials |
| NCT00309101 | An Open Study for Steroid Resistant, Non-Thymectomized MG Patients | completed | Phase 3 | 11 | Astellas Pharma IncINDUSTRY | 1 | Jun 3, 2009 | clinicaltrials |
| NCT00328588 | LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy | completed | Phase 2 | 37 | Astellas Pharma IncINDUSTRY | 3 | Jan 2, 2008 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials